Alzai Health Corp.
ALZI.V
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.89M
Close$
Share Statistics
| Market cap | $19.89 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $- |
| Beta | -0.03 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Alzai Health Corp.
CEO: Hayim Raclaw Alzai Health Corp. develops a disease risk screening platform, enabling disease prevention and early disease diagnosis to improve patient outcomes. The company was founded by Hayim Raclaw, Roy Kait and Ofri Kait on November 15, 2024 and is headquartered in Toronto, Canada.